ATOSSA THERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

ATOSSA THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 8.61 million shares for the year ending 2025.

  • ATOSSA THERAPEUTICS, INC. showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from ATOSSA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), ATOSSA THERAPEUTICS, INC.'s Common Stock Shares Outstanding has declined by 23.5%.
  • Historical annual values: Fiscal year 2025: 8.61 million shares | Fiscal year 2024: 8.61 million shares | Fiscal year 2023: 125.30 million shares | Fiscal year 2022: 126.62 million shares | Fiscal year 2021: 126.62 million shares | Fiscal year 2020: 47.55 million shares | Fiscal year 2019: 9.13 million shares | Fiscal year 2018: 5.85 million shares | Fiscal year 2017: 2.65 million shares | Fiscal year 2016: 3.79 million shares | Fiscal year 2015: 2.18 million shares | Fiscal year 2014: 24.56 million shares | Fiscal year 2013: 18.57 million shares | Fiscal year 2012: 12.92 million shares | Fiscal year 2011: 11.26 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: